Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors

FDA & EMA

FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma

ONCOLife

Reengineering CAR-T Cells to Last Longer in the Fight Against Cancer and HIV

ONCOLife

Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Complete Response Rate and PDC

ONCOLife

Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity

ONCOLife

Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target

ONCOLife

PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%

Clinical Trials

TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias

ONCOLife

Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer

ONCOLife

Colibactin’s Molecular Blueprint Exposes How a Gut Microbial Toxin Triggers Colorectal Cancer

ONCOLife Issues

Featured Articles

New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities

26 March 2026

A Nature study identifies a previously unknown protein modification, O-2-hydroxyglutarylation, driven by the oncometabolite D2HG in IDH-mutant cancers. The findings reveal a new link between altered metabolism and cancer signaling, with potential therapeutic i...

Trending Articles

GSK’s ADC Risvutatug Rezetecan Earns FDA Orphan Drug Status for Small Cell Lung Cancer

Ribociclib Maintains Long-Term Disease Control in HR+ HER2 Metastatic Breast Cancer

Clinical Trials

9 December 2025

Preoperative Radiation May Improve Immune Response in HR+ HER2- Breast Cancer

Clinical Trials

11 December 2025

Tucatinib Combination Cuts Progression Risk by 36% in HER2+ Metastatic Breast Cancer

Clinical Trials

10 December 2025

Giredestrant Cuts Risk of Invasive Recurrence by 30% in Early ER+ Breast Cancer

Clinical Trials

10 December 2025

CAR T Anito cel Delivers Deep, Durable Responses in R&R Multiple Myeloma

Lunsumio Combo Deliver High Response Rates in Follicular and Large B-Cell Lymphomas

ONCOLife

8 December 2025

Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies

Biotech

2 December 2025

Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery

ONCOLife

2 December 2025

Enozertinib Shows Strong Systemic and CNS Activity in EGFR Exon 20+ NSC Lung Cancer

Clinical Trials

6 December 2025

Blood-Based cfDNA Test Demonstrates Potential for Detecting Lung Cancer in Nonsmokers

FDA Approves Durvalumab as First Perioperative Immunotherapy for GEJ Cancers

FDA & EMA

26 November 2025

FDA Approves Keytruda–Padcev Combo as First Perioperative Treatment for Bladder Cancer

FDA & EMA

24 November 2025

Sevabertinib Wins FDA Approval with Strong Responses in HER2+ NSC Lung Cancer

FDA & EMA

20 November 2025

FDA Approves Epcoritamab-bysp as the First Bispecific Antibody for Follicular Lymphoma

FDA & EMA

19 November 2025